Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
232.87
-1.31 (-0.56%)
Apr 20, 2026, 12:19 PM EDT - Market open

Johnson & Johnson Revenue

Johnson & Johnson had revenue of $24.06B in the quarter ending March 31, 2026, with 9.91% growth. This brings the company's revenue in the last twelve months to $96.36B, up 7.87% year-over-year. In the year 2025, Johnson & Johnson had annual revenue of $94.19B with 6.05% growth.

Revenue (ttm)
$96.36B
Revenue Growth
+7.87%
P/S Ratio
5.85
Revenue / Employee
$697,265
Employees
138,200
Market Cap
560.89B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 28, 202594.19B5.37B6.05%
Dec 29, 202488.82B3.66B4.30%
Dec 31, 202385.16B5.17B6.46%
Jan 1, 202379.99B1.25B1.59%
Jan 2, 202278.74B-3.84B-4.65%
Jan 3, 202182.58B525.00M0.64%
Dec 29, 201982.06B478.00M0.59%
Dec 30, 201881.58B5.13B6.71%
Dec 31, 201776.45B4.56B6.34%
Jan 1, 201771.89B1.82B2.59%
Jan 3, 201670.07B-4.26B-5.73%
Dec 28, 201474.33B3.02B4.23%
Dec 29, 201371.31B4.09B6.08%
Dec 30, 201267.22B2.19B3.37%
Jan 1, 201265.03B3.44B5.59%
Jan 2, 201161.59B-310.00M-0.50%
Jan 3, 201061.90B-1.85B-2.90%
Dec 28, 200863.75B2.65B4.34%
Dec 30, 200761.10B7.77B14.57%
Dec 31, 200653.32B2.81B5.56%
Jan 1, 200650.51B3.17B6.69%
Jan 2, 200547.35B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Eli Lilly and Company65.18B
Merck & Co.65.01B
Pfizer62.58B
AbbVie61.16B
AstraZeneca58.74B
Novartis AG56.67B
Sanofi54.85B
Novo Nordisk48.59B
Revenue Rankings